• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Talkspace Inc.

    3/9/26 8:29:37 AM ET
    $TALK
    Medical/Nursing Services
    Health Care
    Get the next $TALK alert in real time by email
    DEFA14A 1 defa14a.htm
    false0001803901DENASDAQNASDAQ00018039012026-03-092026-03-090001803901us-gaap:CommonStockMember2026-03-092026-03-090001803901talk:WarrantsToPurchaseCommonStockMember2026-03-092026-03-09


     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
     WASHINGTON, D.C. 20549



    FORM 8-K

    CURRENT REPORT
    PURSUANT TO SECTION 13 OR 15(D)
    OF THE SECURITIES EXCHANGE ACT OF 1934



    Date of Report (Date of earliest event reported):  March 9, 2026

    Talkspace, Inc.
     (Exact name of registrant as specified in its charter)



    Delaware
      001-39314
      84-4636604
    (State or other jurisdiction
    of incorporation)
     
    (Commission
    File Number)
     
    (IRS Employer
    Identification No.)

    622 Third Avenue
    New York, New York 10017
    (Address of principal executive offices) (Zip Code)

    (212) 284-7206
    (Registrant’s telephone number, including area code)

    Not Applicable
    (Former name or former address, if changed since last report)



    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☒
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

    Title of each class
     
    Trading symbol(s)
     
    Name of each exchange on which registered
    Common stock, $0.0001 par value per share
     
    TALK
     
    Nasdaq Global Select Market
    Warrants to purchase common stock
      TALKW
      Nasdaq Global Select Market

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging Growth Company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




    Item 8.01  Other Events.

    On March 9, 2026, Talkspace, Inc. (the “Company”) issued a press release announcing the entry into an Agreement and Plan of Merger (the “Merger Agreement”) with Universal Health Services, Inc., a Delaware corporation (“Parent”), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent (“Merger Sub”). Subject to the terms and conditions of the Merger Agreement, Merger Sub will be merged with and into the Company (the “Merger”), with the Company surviving the Merger as an indirect wholly owned subsidiary of Parent.

    A copy of the press release is attached as Exhibit 99.1 hereto and is incorporated herein by reference. The terms of the Merger Agreement will be described in a subsequent filing on Form 8-K.

    Item 9.01  Financial Statements and Exhibits.

    (d)          Exhibits.

    Exhibit
    Number
     
    Description of Exhibit
         
    99.1
     
    Joint Press Release, dated March 9, 2026, issued by Universal Health Services, Inc. and Talkspace, Inc.
    104
     
    Cover Page Interactive Data File (embedded within the Inline XBRL document)

    Forward-Looking Statements

    This release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 regarding the Company, which involves substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. In some cases, forward-looking statements can be identified by the use of forward-looking terms such as “anticipate,” “estimate,” “believe,” “continue,” “could,” “intend,” “may,” “plan,” “potential,” “predict,” “should,” “will,” “expect,” “are confident that,” “objective,” “projection,” “forecast,” “goal,” “guidance,” “outlook,” “effort,” “target,” “would” or the negative of these terms or other comparable terms. Forward-looking statements in this release include, among other things, statements about the potential benefits of the proposed transaction; anticipated accretion and growth rates; plans, objectives, beliefs, expectations and intentions of the Board and the Company management; the financial condition, results of operations and business of the Company; and the anticipated timing of closing of the proposed transaction.

    These forward-looking statements are based on certain assumptions and analyses made by the Company in light of the Company’s experience and perception of historical trends, current conditions and expected future developments, as well as other factors the Company believes are appropriate in the circumstances. These forward-looking statements also are based on the current expectations and beliefs of the management of the Company and are subject to certain known and unknown risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Risks and uncertainties include, among other things, (i) risks related to the satisfaction of the conditions to closing the proposed transaction (including the failure to obtain necessary regulatory approvals) in the anticipated timeframe or at all, including uncertainties as whether the stockholders of the Company will approve the proposed transaction and the possibility that the proposed transaction does not close; (ii) risks related to the possibility that competing offers or acquisition proposals for the Company will be made; (iii) the occurrence of any event, change or other circumstances that could give rise to the termination of the definitive transaction agreement relating to the proposed transaction, including in circumstances which would require the Company to pay a termination fee; (iv) risks related to the ability to realize the anticipated benefits of the proposed transaction, including the possibility that the expected benefits from the proposed transaction will not be realized or will not be realized within the expected time period; (v) the risk that the businesses will not be integrated successfully; (vi) disruption from the proposed transaction making it more difficult to maintain business and operational relationships, including with customers, vendors, service providers and other business counterparties, and the Company’s ability to attract, motivate or retain key executives, employees and other associates; (vii) risk related to the proposed transaction diverting the Company’s management’s attention from ongoing business operations; (viii) negative effects of the announcement of the Merger or the consummation of the proposed transaction on the market price of Company Common Stock and on the Company’s operating results; (ix) the risk of litigation, including shareholder litigation, and/or regulatory actions, including any conditions, limitations or restrictions placed on approvals by any applicable governmental entities, related to the proposed transaction; and (x) (A) other risks and uncertainties discussed in the Company’s Annual Report on Form 10-K, for the fiscal year ended December 31, 2024 and subsequent Quarterly Reports on Form 10-Q (in particular, the risk factors set forth under the headings “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in such Annual Reports and Quarterly Reports), and (B) other risk factors identified from time to time in other filings with the U.S. Securities and Exchange Commission (the “SEC”). Filings with the SEC are available on the SEC’s website at http://www.sec.gov.



    The list of factors that may affect actual results and the accuracy of forward-looking statements is illustrative and is not intended to be exhaustive. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to update any of these forward-looking statements as the result of new information or to reflect events or circumstances after the date of this communication or to reflect actual outcomes, expect as required by law, and expressly disclaims any obligation to revise or update any forward-looking statement to reflect future events or circumstances.

    Additional Information about the Proposed Transaction and Where to Find It

    In connection with the proposed transaction, the Company intends to file relevant materials with the SEC, including preliminary and definitive proxy statements relating to the proposed transaction. The definitive proxy statement will be mailed to the Company’s stockholders in connection with the proposed transaction. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND SECURITY HOLDERS OF THE COMPANY ARE URGED TO READ THE PRELIMINARY AND DEFINITIVE PROXY STATEMENTS AND ALL RELEVANT DOCUMENTS TO BE FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION OR INCORPORATED BY REFERENCE IN THE PROXY STATEMENT WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders may obtain free copies of these documents (if and when they are available) and other related documents filed with the SEC at the SEC’s web site at www.sec.gov, and on the Company’s website at www.talkspace.com.

    Participants in the Solicitation

    The Company and its directors and executive officers and other members of management and employees may, under SEC rules, be deemed participants in the solicitation of proxies from the stockholders of the Company in connection with the proposed transaction. Information regarding the Company’s directors and executive officers can be found in the Company’s definitive proxy statement on Schedule 14A for the 2025 Annual Meeting of Stockholders, which was filed with the SEC on April 30, 2025 and subsequent statements of beneficial ownership on file with the SEC. These documents are available free of charge at the SEC’s web site at www.sec.gov and on the Company’s website at www.talkspace.com. Additional information regarding the interest of the participants in the solicitation of the Company’s stockholders, which may, in some cases, be different than those of the Company’s stockholders generally, will be set forth in the proxy statement related to the proposed transaction described above and other relevant materials to be filed with the SEC if and when they become available.




    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

      TALKSPACE, INC.  
           

    By:
    /s/ Ian Harris  
        Name: Ian Harris  
        Title: Chief Financial Officer  
           
    Date: March 9, 2026



    Get the next $TALK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TALK

    DatePrice TargetRatingAnalyst
    12/9/2025$3.50Equal Weight
    Barclays
    10/31/2025$5.00Hold → Buy
    Needham
    4/3/2025$5.00Buy
    Canaccord Genuity
    12/9/2024$4.50Overweight
    KeyBanc Capital Markets
    12/4/2024$5.00Outperform
    Mizuho
    11/20/2024$5.00Outperform
    Northland Capital
    7/1/2024Hold
    Needham
    1/3/2024$2.50Equal Weight
    Barclays
    More analyst ratings

    $TALK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Universal Health Services, Inc. to Acquire Talkspace, Inc.

    Industry-leading virtual behavioral healthcare platform accelerates outpatient strategy with expanded access to careKING OF PRUSSIA, Pa. and NEW YORK, March 9, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE:UHS) announced today that it has entered into a definitive agreement to acquire Talkspace, Inc. (NASDAQ:TALK) for $5.25 per share. The enterprise value for the transaction is approximately $835 million, which UHS intends to finance with borrowings pursuant to its existing revolving credit facility. Talkspace is a leading virtual behavioral healthcare company, with

    3/9/26 7:39:00 AM ET
    $TALK
    $UHS
    $UHT
    Medical/Nursing Services
    Health Care
    Hospital/Nursing Management
    Real Estate Investment Trusts

    Talkspace to Participate in Upcoming Investor Conferences

    NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Talkspace (NASDAQ:TALK), a leading behavioral healthcare company, today announced that members of senior management will participate in the following upcoming investor conferences: The TD Cowen 46th Annual Health Care Conference, being held in Boston, including 1x1 meetings with investors on Monday, March 2, 2026.The Mizuho Healthcare Technology Conference, being held virtually, including 1x1 meetings with investors on Thursday, March 5, 2026.The Barclays 28th Annual Global Healthcare Conference, being held in Miami, including 1x1 meetings with investors and a fireside chat on Tuesday, March 10, 2026 at 2:30pm ET.The KeyBanc Capital Markets Heal

    2/25/26 4:05:00 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Ahead of World Teen Mental Wellness Day (March 2), Talkspace Shares Top Teen Mental Health Tips for Families

    In recognition of World Teen Mental Wellness Day, Talkspace, a leading online behavioral health platform, is sharing expert-backed guidance to help teens and parents navigate the growing mental health challenges facing young people today. "Teen years can be emotionally intense, and many young people are carrying more stress, anxiety, and pressure than ever before," said Dr. Nikole Benders-Hadi, Chief Medical Officer at Talkspace. "World Teen Mental Wellness Day is an important reminder that mental health support should be part of everyday life — not something we only talk about when things feel overwhelming." Despite the surge in teen anxiety and depression, nearly half of those struggl

    2/25/26 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    SEC Filings

    View All

    SEC Form DEFA14A filed by Talkspace Inc.

    DEFA14A - Talkspace, Inc. (0001803901) (Filer)

    3/9/26 5:00:20 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    SEC Form DEFA14A filed by Talkspace Inc.

    DEFA14A - Talkspace, Inc. (0001803901) (Filer)

    3/9/26 4:38:00 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Talkspace, Inc. (0001803901) (Filer)

    3/9/26 4:34:41 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $TALK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $TALK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Barclays initiated coverage on Talkspace with a new price target

    Barclays initiated coverage of Talkspace with a rating of Equal Weight and set a new price target of $3.50

    12/9/25 8:53:40 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace upgraded by Needham with a new price target

    Needham upgraded Talkspace from Hold to Buy and set a new price target of $5.00

    10/31/25 8:16:48 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Canaccord Genuity initiated coverage on Talkspace with a new price target

    Canaccord Genuity initiated coverage of Talkspace with a rating of Buy and set a new price target of $5.00

    4/3/25 8:18:33 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Director Braunstein Douglas L was granted 3,757 shares, increasing direct ownership by 0.18% to 2,083,901 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    3/3/26 9:30:08 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Director Pawar Madhu was granted 2,147 shares, increasing direct ownership by 0.56% to 388,014 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    3/3/26 9:30:11 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Director Shachar Erez was granted 2,684 shares, increasing direct ownership by 0.64% to 424,644 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    3/3/26 9:30:02 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Chief Financial Officer Harris Ian Jiro bought $86,037 worth of shares (30,844 units at $2.79), increasing direct ownership by 5% to 615,015 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    3/5/25 4:00:06 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Chief Executive Officer Cohen Jon R bought $214,500 worth of shares (75,000 units at $2.86), increasing direct ownership by 3% to 2,267,980 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    3/3/25 9:30:03 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Chief Legal Officer, Secretary Reilly John Charles bought $10,242 worth of shares (3,600 units at $2.85), increasing direct ownership by 0.41% to 889,806 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    2/28/25 9:55:04 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    Financials

    Live finance-specific insights

    View All

    Talkspace Announces Fourth Quarter and Full Year 2025 Results

    4Q 2025 total revenue grew 29% year-over-year to $63.0 million4Q 2025 net income of $4.8 million and adjusted EBITDA1 of $6.6 million Full-year 2025 total revenue grew 22% year-over-year to $228.9 millionFull-year 2025 net income of $7.8 millionFull-year 2025 adjusted EBITDA1 grew 127% year-over-year to $15.8 million  NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace" or the "Company") (NASDAQ:TALK), today reported fourth quarter and full year 2025 financial results.   Three Months EndedDecember 31, Year EndedDecember 31,   2025 2024 2025 2024   Results % Variancefrom PriorYear Results % Variancefrom PriorYear (In thousands unless otherwise noted)Unaudited Unaudited  

    2/19/26 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace to Report Fourth Quarter and Full Year 2025 Results and Host Conference Call

    NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Talkspace (NASDAQ:TALK),  a leading behavioral healthcare company, today announced that it will release its fourth quarter and full year 2025 results on Thursday, February 19, 2026 before market open and host a conference call to review the results at 8:30am ET. Conference Call DetailsThe conference call will be available via audio webcast at https://investors.talkspace.com/ and can also be accessed by dialing (800) 225-9448 for U.S. participants, or (203) 518-9708 for international participants, and using conference ID TALKQ425. A replay will be available shortly after the call's completion and remain available for approximately 90 days. About

    2/5/26 4:05:00 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace Announces Third Quarter 2025 Results

    3Q 2025 Total revenue grew 25% year-over-year to $59.4 million driven by 42% year-over-year growth in Payor revenue 3Q 2025 Net income of $3.3 million and adjusted EBITDA¹ of $5.0 million 3Q 2025 Share repurchases of $8.8 million NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace" or the "Company") (NASDAQ:TALK), today reported third quarter 2025 financial results.   Three Months EndedSeptember 30,  Nine Months EndedSeptember 30,   2025  2024  2025  2024 Unaudited Results  % Variance from Prior Year  Results  % Variance from Prior Year (In thousands unless otherwise noted)            Number of completed Payor sessions during the period  432.2   37%  1,167.3   30%Num

    10/30/25 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    Leadership Updates

    Live Leadership Updates

    View All

    Talkspace Partners With Amazon Health Services to Help Millions Discover Mental Health Benefits

    New collaboration aims to improve awareness of, and expand access to, online therapy and psychiatry services to the 150+ million people who have Talkspace as a covered benefit Talkspace (NASDAQ:TALK), a leading online behavioral health care company, today announced a partnership with Amazon Health Services to increase awareness and discoverability of its mental health care services on Amazon.com. Talkspace is the first virtual behavioral health provider to join Amazon Health Services' program to help individuals discover and enroll in their health insurance benefits at no extra cost or for a small copay. With more than 5,000 therapists and providers across 50 states, Talkspace improves acc

    9/17/24 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace and the Professional Tennis Players Association Join Forces to Support Mental Health of Athletes Year Round

    Today, Talkspace (NASDAQ:TALK), a leading online behavioral health care company, announced its partnership with the Professional Tennis Players Association (PTPA), global advocates for professional tennis players. Talkspace will serve as the PTPA's exclusive mental health technology partner, granting players, their families, and their support teams free, 24/7 access to Talkspace's self-guided therapy app, Talkspace Go, as well as discounted access to its virtual therapy offering. "Talkspace is honored to join forces with the PTPA as its exclusive mental health provider, dedicated to delivering high-quality, evidence-based support where and when players need it. This collaboration undersco

    8/28/24 9:06:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace Appoints John Mooney as Chief Product Officer

    NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Today Talkspace (NASDAQ:TALK), a leading online behavioral health care company, announced the appointment of John Mooney as its new Chief Product Officer, to lead the company's growth initiatives, product strategy and design. Through his work for startup digital health, behavioral health, and diagnostics companies, Mr. Mooney has deep domain expertise in healthcare data, building out platform capabilities and optimizing workflows. "John has spent his career driving innovation for a range of high-growth, high-performing healthcare companies," said Dr. Jon Cohen, Chief Executive Officer, Talkspace. "We look forward to his expertise leveraging dat

    6/5/24 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Talkspace Inc. (Amendment)

    SC 13G/A - Talkspace, Inc. (0001803901) (Subject)

    2/14/24 4:24:23 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Talkspace Inc. (Amendment)

    SC 13G/A - Talkspace, Inc. (0001803901) (Subject)

    2/9/24 7:24:33 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    SEC Form SC 13D/A filed by Talkspace Inc. (Amendment)

    SC 13D/A - Talkspace, Inc. (0001803901) (Subject)

    10/5/23 6:41:35 PM ET
    $TALK
    Medical/Nursing Services
    Health Care